Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 29 10 2019
accepted: 12 03 2020
pubmed: 1 4 2020
medline: 29 4 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

Human immunodeficiency virus-2 (HIV-2) is endemic in some countries in West Africa. Due to the lower prevalence in industrialized countries, there is limited experience and knowledge on the management of individuals living with HIV-2 in Europe. Compared to HIV-1, there are differential characteristics of HIV-2 regarding diagnostic procedures, the clinical course, and, most importantly, antiretroviral therapy. We integrated the published literature on HIV-2 (studies and reports on epidemiology, diagnostics, the clinical course, and treatment), as well as expert experience in diagnosing and clinical care, to provide recommendations for a present standard of medical care of those living with HIV-2 in Western European countries, including an overview of strategies for diagnosis, monitoring, and treatment, with suggestions for effective drug combinations for first- and second-line treatments, post-exposure prophylaxis, and the prevention of mother-to-child transmission, as well as listings of mutations related to HIV-2 drug resistance and C-C motif chemokine receptor type 5 and C-X-C motif chemokine receptor type 4 coreceptor tropism.

Identifiants

pubmed: 32227124
pii: 5813600
doi: 10.1093/cid/ciaa275
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

503-509

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Dirk Berzow (D)

Praxis for Infectiology, Hamburg, Germany.
Deutsche Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung HIV-Infizierter (DAGNAE) Berlin, Germany.

Diane Descamps (D)

Laboratoire de Virologie, Hôpital Bichat-Claude Bernard, Paris, France.
Université de Paris, Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR),1137, Laboratory Infection, Antimicrobials, Modelling, Evolution (IAME), Paris, France.

Martin Obermeier (M)

Deutsche Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung HIV-Infizierter (DAGNAE) Berlin, Germany.
Medical Center for Infectious Diseases, Berlin, Germany.
Gesellschaft für Virologie e.V., Freiburg, Germany.

Charlotte Charpentier (C)

Laboratoire de Virologie, Hôpital Bichat-Claude Bernard, Paris, France.
Université de Paris, Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR),1137, Laboratory Infection, Antimicrobials, Modelling, Evolution (IAME), Paris, France.

Rolf Kaiser (R)

Gesellschaft für Virologie e.V., Freiburg, Germany.
Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
German AIDS Society (Deutsche AIDS-Gesellschaft, DAIG), Hamburg, Germany.
Paul-Ehrlich-Gesellschaft für Chemotherapie, Rheinbach, Germany.

Lutz Guertler (L)

Gesellschaft für Virologie e.V., Freiburg, Germany.
German AIDS Society (Deutsche AIDS-Gesellschaft, DAIG), Hamburg, Germany.
National Reference Center for Retroviruses, Max von Pettenkofer Institute for Hygiene and Medical Microbiology, University of Munich, Munich, Germany.

Josef Eberle (J)

Gesellschaft für Virologie e.V., Freiburg, Germany.
German AIDS Society (Deutsche AIDS-Gesellschaft, DAIG), Hamburg, Germany.
National Reference Center for Retroviruses, Max von Pettenkofer Institute for Hygiene and Medical Microbiology, University of Munich, Munich, Germany.

Annemarie Wensing (A)

European AIDS Clinical Society, Brussels, Belgium.
Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.

Saleta Sierra (S)

Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.

Jean Ruelle (J)

Laboratories Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Perpetua Gomes (P)

Instituto Universitário Egas Moniz, Lisboa, Portugal.
Molecular Biology Laboratory, Laboratório de Biologia Molecular, Centro Hospitalar de Lisboa Ocidental, Egas Moniz Hospital, Lisboa, Portugal.

Kamal Mansinho (K)

Centro Hospitalar de Lisboa Occidental, Hospital de Egas Moniz, Lisboa, Portugal.

Ninon Taylor (N)

Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.

Björn Jensen (B)

Paul-Ehrlich-Gesellschaft für Chemotherapie, Rheinbach, Germany.
Department of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine University Hospital, Düsseldorf, Germany.

Matthias Döring (M)

Department for Computational Biology and Applied Algorithmics, Max-Planck Institute for Informatics, Saarland Informatics Campus, Saarbrücken, Germany.

Martin Stürmer (M)

Medizinisches Versorgungszentrum, Frankfurt am Main, Germany.

Jürgen Rockstroh (J)

European AIDS Clinical Society, Brussels, Belgium.
Department of Medicine I, Bonn University Hospital, Bonn, Germany.

Ricardo Camacho (R)

Katholieke Universiteit, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH